Overview

Glycemia in Diabetic Elders Trial

Status:
Terminated

Trial end date:
2017-02-01

Target enrollment:

Participant gender:

Summary

This study is a pilot randomized controlled trial of 30 elderly type 2 diabetes patients conducted at the MODEL Clinical Research (MODEL), Research Division of Bay West Endocrinology Associates in Baltimore, Maryland. The investigators hypothesized that compared to a regimen base solely on traditional drugs, a regimen including newer drugs will achieve glycemic target faster and induce less hypoglycemia, weight gain, and other side effects, over the short run.

Phase:

Phase 4

Details

Lead Sponsor:

Johns Hopkins University

Treatments:

Dipeptidyl-Peptidase IV Inhibitors
Incretins
Insulin
Insulin, Globin Zinc
Islet Amyloid Polypeptide
Metformin